The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells.
Open accessAbstract
This study was undertaken to determine whether acute phase proteins (APP) induce the synthesis of interleukin 1 beta (IL-1 beta) and its specific antagonist, IL-1 receptor antagonist (IL-1Ra), in human peripheral blood mononuclear cells (PBMC). PBMC from healthy volunteers were incubated with C-reactive protein (CRP), alpha 1-antitrypsin (alpha 1-AT), or alpha 1-acid glycoprotein (AGP), and the levels of IL-1 beta and IL-1Ra produced were measured by specific radioimmunoassay. To evaluate the effects of alpha 1-AT further, a synthetic pentapeptide FVYLI corresponding to the minimal binding sequence for the serpine-enzyme complex receptor was also evaluated. PBMC incubated for 24 h with CRP, alpha 1-AT, or the pentapeptide FVYLI synthesized large quantities of IL-1Ra, 5-10-fold greater than the amount of IL-1 beta produced by these cells. AGP induced significantly less IL-1Ra than the other APP tested. These effects were shown to be specific, in that polyclonal antibodies against CRP, alpha 1-AT, and AGP eliminated the cytokine production induced by these respective proteins. CRP, alpha 1-AT, FVYLI, and AGP were synergistic with low concentrations of endotoxin in the induction of both IL-1Ra and IL-1 beta synthesis. We suggest that the preferential induction of IL-1Ra by APP may contribute to their antiinflammatory effects and provide an important regulatory signal for the acute phase response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
Self-citationGalactosamine-induced sensitization to the lethal effects of endotoxin.
Galanos, C., Freudenberg, M. A., & Reutter, W. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.11.5939 · Cited by 929
Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro
Dinarello, C. A., & Thompson, R. C. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90142-g · Cited by 724
Self-citationInterleukin 1 receptor antagonist. A new member of the interleukin 1 family.
Arend, W. P. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115453 · Cited by 595
Pulmonary Emphysema and Alpha1‐Antitrypsin Deficiency
ERIKSSON, S. (1964) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1964.tb00567.x · Cited by 459
Dripps, D. J., Brandhuber, B. J., Thompson, R. C., & Eisenberg, S. P. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99230-6 · Cited by 452
A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits
Wakabayashi, G., Gelfand, J. A., Burke, J. F., Thompson, R. C., & Dinarello, C. A. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.3.1825816 · Cited by 423
Self-citationInduction of inflammatory cytokine release from cultured human monocytes by C-reactive protein
Ballou, S. P., & Lozanski, G. (1992) · Cytokine · doi:10.1016/1043-4666(92)90079-7 · Cited by 368
A urine inhibitor of interleukin 1 activity that blocks ligand binding.
Seckinger, P., Lowenthal, J. W., Williamson, K., Dayer, J. M., & MacDonald, H. R. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.5.1546 · Cited by 345
De Graaf, T. W., Van der Stelt, M. E., Anbergen, M. G., & van Dijk, W. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.3.657 · Cited by 224
Cited by
Black, S., Kushner, I., & Samols, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400025200 · Cited by 1,844
Fournier, T., Medjoubi-N, N., & Porquet, D. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00153-9 · Cited by 998
Inflammatory mechanisms in the regulation of insulin resistance
Tilg, H., & Moschen, A. R. (2008) · Molecular Medicine · doi:10.2119/2007-00119.tilg · Cited by 779
Self-citationIL-6 and APPs: anti-inflammatory and immunosuppressive mediators
Tilg, H., Dinarello, C. A., & Mier, J. W. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01103-1 · Cited by 633
Self-citationC-reactive protein: Ligands, receptors and role in inflammation
Marnell, L., Mold, C., & Du Clos, T. W. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.08.004 · Cited by 627
Danis, V. A., Millington, M., Hyland, V. J., & Grennan, D. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb05549.x · Cited by 530
α1-Acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties
Hochepied, T., Berger, F. G., Baumann, H., & Libert, C. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00054-0 · Cited by 457
C-Reactive Protein: An Activator of Innate Immunity and a Modulator of Adaptive Immunity
Du Clos, T. W., & Mold, C. (2004) · Immunologic Research · doi:10.1385/ir:30:3:261 · Cited by 407
C-Reactive Protein Colocalizes With Complement in Human Hearts During Acute Myocardial Infarction
Lagrand, W. K., Niessen, H. W. M., Wolbink, G.-J., Jaspars, L. H., Visser, C. A., Verheugt, F. W. A., Meijer, C. J. L. M., & Hack, C. E. (1997) · Circulation · doi:10.1161/01.cir.95.1.97 · Cited by 388
HUMAN ALPHA-1-GLYCOPROTEIN AND ITS INTERACTIONS WITH DRUGS†,‡
Israili, Z. H., & Dayton, P. G. (2001) · Drug Metabolism Reviews · doi:10.1081/dmr-100104402 · Cited by 367
The discovery of α1-antitrypsin and its role in health and disease
Janciauskiene, S. M., Bals, R., Koczulla, R., Vogelmeier, C., Köhnlein, T., & Welte, T. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.02.002 · Cited by 348
Greene, C. M., Marciniak, S. J., Teckman, J., Ferrarotti, I., Brantly, M. L., Lomas, D. A., Stoller, J. K., & McElvaney, N. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.51 · Cited by 324
C-reactive protein and inflammation: conformational changes affect function
Wu, Y., Potempa, L. A., El Kebir, D., & Filep, J. G. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0149 · Cited by 285
Hack, C. E., Aarden, L. A., & Thus, L. G. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60597-0 · Cited by 280
Such stuff as dreams are made on: mediator-directed therapy in sepsis
Marshall, J. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1084 · Cited by 264
Mackowiak, P. A. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.17.1870 · Cited by 254
Acute-phase protein synthesis: a key feature of innate immune functions of the liver
Ehlting, C., Wolf, S. D., & Bode, J. G. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0209 · Cited by 115
Metadata
- Authors
- Tilg, H., Vannier, E., Vachino, G., Dinarello, C. A., & Mier, J. W.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1993-11-01
- Volume
- 178
- Issue
- 5
- Pages
- 1629-1636
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2118606452
- Cited by
- 256
- References
- 31
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.